16 December 2025 : Original article
Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY)
Sang-Hoon Kim BCDEF 1, Shin Hwang ABG 1*, Bong-Wan Kim ABG 2, Dong Jin Joo ABD 3, Kwang-Woong Lee ABD 4, Gyu-Seong Choi AD 5, Je Ho Ryu ABD 6, Dong-Sik Kim ABD 7, Dongho Choi ABD 8, Jai Young Cho ABD 9, Young Kyoung You ABD 10, Dongho Choi ABD 11, Tae-Seok Kim ABD 12, PyoungJae Park ABD 13DOI: 10.12659/AOT.949241
Ann Transplant 2025; 30:e949241
Figure 7 Kaplan-Meier curves for overall survival (OS) according to tumor recurrence. (A) OS according to recurrence status. OS of the 9 recipients with recurrence according to everolimus administration within (B) 1 month, (C) 6 months, and (D) 1 year after liver transplantation (LT).






